M. Anne McGeorge's most recent trade in Oncology Institute Inc (The) was a trade of 56,000 Common stock done . Disclosure was reported to the exchange on Nov. 22, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Oncology Institute Inc (The) | Anne M. McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 56,000 | 183,346 | - | 0 | Common stock | |
Dianthus Therapeutics Inc | Anne M. McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
Oncology Institute Inc (The) | M. Anne McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2023 | 56,000 | 127,346 | - | 0 | Common stock | |
Oncology Institute Inc (The) | Anne M. McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 26,247 | 71,346 | - | 0 | Common stock | |
Oncology Institute Inc (The) | Anne M. McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 22,708 | 45,099 | - | 0 | Common Stock | |
Oncology Institute Inc (The) | Anne M. McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 15,994 | 15,994 | - | 0 | Common stock | |
Oncology Institute Inc (The) | Anne M. McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 6,397 | 22,391 | - | 0 | Common stock |